Fund comparison · from official SEC filings

IDNA vs XBI: how much do they overlap?

iShares Genomics Immunology and Healthcare ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF
Holdings overlap
14%
of assets, by weight
Shared positions
25
of 62 / 155 holdings
IDNA expense ratio
0.47%
net, per year
XBI expense ratio
0.35%
net, per year
Shared holdings
Company
IDNA
XBI
R
RVMDREVOLUTION MEDICINES INC
5.70%
1.03%
M
MRNAMODERNA INC
5.22%
0.96%
E
EXELEXELIXIS INC
3.16%
1.08%
T
TWSTTWIST BIOSCIENCE CORP
3.15%
1.07%
R
REGNREGENERON PHARMACEUTICALS
3.10%
1.05%
V
VRTXVERTEX PHARMACEUTICALS INC
2.96%
0.96%
I
INCYINCYTE CORP
2.93%
1.05%
I
IDYAIDEAYA BIOSCIENCES INC
2.25%
0.68%
I
IBRXIMMUNITYBIO INC
2.17%
0.98%
R
RCUSARCUS BIOSCIENCES INC
1.77%
0.58%
C
CRSPCRISPR THERAPEUTICS AG
1.50%
1.01%
N
NVAXNOVAVAX INC
1.09%
0.47%
I
IOVAIOVANCE BIOTHERAPEUTICS INC
1.03%
0.36%
V
VIRVIR BIOTECHNOLOGY INC
0.89%
0.28%
C
CRVSCORVUS PHARMACEUTICALS INC
0.80%
0.39%
J
JANXJANUX THERAPEUTICS INC
0.71%
0.25%
K
KURAKURA ONCOLOGY INC
0.69%
0.26%
N
NTLAINTELLIA THERAPEUTICS INC
0.47%
0.60%
C
CTMXCYTOMX THERAPEUTICS INC
0.50%
0.26%
O
OCGNOCUGEN INC
0.49%
0.12%
R
RIGLRIGEL PHARMACEUTICALS INC
0.47%
0.24%
V
VSTMVERASTEM INC
0.33%
0.13%
X
XNCRXENCOR INC
0.25%
0.21%
P
PRMEPRIME MEDICINE INC
0.10%
0.17%
O
OABIOMNIAB INC
0.00%
0.00%
Only in IDNA
B
BISXXBCF INSTITUTIONAL-SL AGNCY
17.45%
I
IPSEFIPSEN
4.36%
B
BAYZFBAYER AG-REG
3.64%
T
TKPHFTAKEDA PHARMACEUTICAL CO LTD
3.51%
M
MRKMERCK & CO. INC.
3.45%
G
GLAXFGSK PLC
3.43%
B
BNTXBIONTECH SE-ADR
3.39%
R
RHHVFROCHE HOLDING AG
3.32%
S
SNYNFSANOFI
2.98%
G
GNMSFGENMAB A/S
2.63%
C
CAICARIS LIFE SCIENCES INC
2.03%
O
OPHLFONO PHARMACEUTICAL CO LTD
1.55%
2
2595GENFLEET THERAPEUTICS SHAN-H
1.00%
N
NUVBNUVATION BIO INC
0.98%
A
ABCLABCELLERA BIOLOGICS INC
0.88%
6
6887SUNSHINE LAKE PHARMA CO LT-H
0.52%
1
174900ABCLON INC
0.47%
S
SGBCFSHANGHAI HENLIUS BIOTECH I-H
0.42%
P
PACBPACIFIC BIOSCIENCES OF CALIF
0.40%
D
DSGNDESIGN THERAPEUTICS INC
0.39%
I
INRLFVALNEVA SE
0.37%
D
DNAGINKGO BIOWORKS HOLDINGS INC
0.33%
A
ALVOALVOTECH SA
0.33%
P
PSNLPERSONALIS INC
0.27%
2
2591GUANGZHOU INNOGEN PHARMACE-H
0.11%
Only in XBI
G
GVMXXSTATE ST INST US GOV MM-PREM
7.47%
1
1JKAPELLIS PHARMACEUTICALS INC
1.70%
A
ALKSALKERMES PLC
1.34%
M
MDGLMADRIGAL PHARMACEUTICALS INC
1.28%
T
TGTXTG THERAPEUTICS INC
1.25%
I
INSMINSMED INC
1.24%
S
SRRKSCHOLAR ROCK HOLDING CORP
1.20%
A
APGEAPOGEE THERAPEUTICS INC
1.19%
P
PTGXPROTAGONIST THERAPEUTICS INC
1.15%
S
SMMTSUMMIT THERAPEUTICS INC
1.15%
U
UTHRUNITED THERAPEUTICS CORP
1.15%
P
PRAXPRAXIS PRECISION MEDICINES I
1.14%
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.14%
C
COGTCOGENT BIOSCIENCES INC
1.13%
B
BBIOBRIDGEBIO PHARMA INC
1.10%
P
PTCTPTC THERAPEUTICS INC
1.09%
C
CYTKCYTOKINETICS INC
1.09%
A
ALNYALNYLAM PHARMACEUTICALS INC
1.09%
?
Nuvalent Inc
1.08%
K
KYMRKYMERA THERAPEUTICS INC
1.08%
C
CGONCG ONCOLOGY INC
1.08%
N
NTRANATERA INC
1.07%
N
NBIXNEUROCRINE BIOSCIENCES INC
1.07%
K
KRYSKRYSTAL BIOTECH INC
1.07%
P
PCVXVAXCYTE INC
1.07%
Hold IDNA and XBI together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.